Cargando…
Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014)
Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed at evaluating the clinical features and culpr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689917/ https://www.ncbi.nlm.nih.gov/pubmed/26783389 http://dx.doi.org/10.1155/2015/236703 |
_version_ | 1782406918835273728 |
---|---|
author | Kavoussi, Hossein Rezaei, Mansour Derakhshandeh, Katayoun Moradi, Alireza Ebrahimi, Ali Rashidian, Harif Kavoussi, Reza |
author_facet | Kavoussi, Hossein Rezaei, Mansour Derakhshandeh, Katayoun Moradi, Alireza Ebrahimi, Ali Rashidian, Harif Kavoussi, Reza |
author_sort | Kavoussi, Hossein |
collection | PubMed |
description | Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed at evaluating the clinical features and culprit drugs in generalized fixed drug eruptions in the west of Iran. Method. This cross-sectional study was carried out on 30 patients with criteria of generalized fixed drug eruption over 9 years. Demographic, clinical, and drug intake information were collected. Results. Out of 30 patients (17 females and 13 males) with the mean age of 26.67 ± 10.21 years, 28 (93.3%) and 2 (6.7%) cases had plaque and bullous clinical presentation, respectively. Upper limbs were the most common (90%) site of involvement. The antibiotic group, especially cotrimoxazole (26.1%), was reported to be the most common offending drug, but the causative drug was not determined in 7 (23.3%) patients. Conclusion. Many cases of generalized fixed drug eruption firstly presented as limited lesions and led to generalized lesion due to repeated intake of the causative drug. No causative drug was found in some patients, which might be associated with concurrent intake of several drugs, multiple FDE, and peculiarity of the patch test. |
format | Online Article Text |
id | pubmed-4689917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46899172016-01-18 Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) Kavoussi, Hossein Rezaei, Mansour Derakhshandeh, Katayoun Moradi, Alireza Ebrahimi, Ali Rashidian, Harif Kavoussi, Reza Dermatol Res Pract Research Article Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed at evaluating the clinical features and culprit drugs in generalized fixed drug eruptions in the west of Iran. Method. This cross-sectional study was carried out on 30 patients with criteria of generalized fixed drug eruption over 9 years. Demographic, clinical, and drug intake information were collected. Results. Out of 30 patients (17 females and 13 males) with the mean age of 26.67 ± 10.21 years, 28 (93.3%) and 2 (6.7%) cases had plaque and bullous clinical presentation, respectively. Upper limbs were the most common (90%) site of involvement. The antibiotic group, especially cotrimoxazole (26.1%), was reported to be the most common offending drug, but the causative drug was not determined in 7 (23.3%) patients. Conclusion. Many cases of generalized fixed drug eruption firstly presented as limited lesions and led to generalized lesion due to repeated intake of the causative drug. No causative drug was found in some patients, which might be associated with concurrent intake of several drugs, multiple FDE, and peculiarity of the patch test. Hindawi Publishing Corporation 2015 2015-12-10 /pmc/articles/PMC4689917/ /pubmed/26783389 http://dx.doi.org/10.1155/2015/236703 Text en Copyright © 2015 Hossein Kavoussi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kavoussi, Hossein Rezaei, Mansour Derakhshandeh, Katayoun Moradi, Alireza Ebrahimi, Ali Rashidian, Harif Kavoussi, Reza Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title | Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title_full | Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title_fullStr | Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title_full_unstemmed | Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title_short | Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014) |
title_sort | clinical features and drug characteristics of patients with generalized fixed drug eruption in the west of iran (2005–2014) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689917/ https://www.ncbi.nlm.nih.gov/pubmed/26783389 http://dx.doi.org/10.1155/2015/236703 |
work_keys_str_mv | AT kavoussihossein clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT rezaeimansour clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT derakhshandehkatayoun clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT moradialireza clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT ebrahimiali clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT rashidianharif clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 AT kavoussireza clinicalfeaturesanddrugcharacteristicsofpatientswithgeneralizedfixeddrugeruptioninthewestofiran20052014 |